Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

22.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.1K
Gene Therapy00:59

Gene Therapy

4.4K
4.4K
What is Genetic Engineering?00:49

What is Genetic Engineering?

70.4K
Overview
70.4K
CRISPR01:59

CRISPR

46.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
46.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

119
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials.

Molecular therapy : the journal of the American Society of Gene Therapy·2022
Same author

Biobehavioral Assessments in BACPAC: Recommendations, Rationale, and Methods.

Pain medicine (Malden, Mass.)·2022
Same author

Stimulated whole-blood cytokine/chemokine responses are associated with interstitial cystitis/bladder pain syndrome phenotypes and features of nociplastic pain: a multidisciplinary approach to the study of chronic pelvic pain research network study.

Pain·2022
Same author

Transient neonatal hemolytic anemia due to the novel gamma globin gene mutation HBG2:C.290T>C, p.Leu97Pro (hemoglobin Wareham).

Pediatric blood & cancer·2022
Same author

Evidence-based interventions to treat chronic low back pain: treatment selection for a personalized medicine approach.

Pain reports·2022
Same author

Patterns of Use in Transesophageal Echocardiography for Liver Transplantation: A Systematic Review.

Seminars in cardiothoracic and vascular anesthesia·2022

Related Experiment Video

Updated: Apr 25, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

7.6K

Curing genetic disease with gene therapy.

David A Williams1

  • 1Boston, Massachusetts.

Transactions of the American Clinical and Climatological Association
|August 16, 2014
PubMed
Summary

New gene therapy vectors show early promise for treating X-linked severe combined immunodeficiency (SCID-X1). These improved viral vectors demonstrate enhanced safety and efficacy in clinical trials, addressing previous concerns with oncogene activation.

Area of Science:

  • Gene therapy
  • Viral vector development
  • Immunology

Background:

  • Viral vectors enable gene transfer for treating genetic diseases, with early successes in blood and immune disorders.
  • Previous gene therapy trials, particularly for X-linked severe combined immunodeficiency (SCID-X1), reported serious adverse events due to oncogene activation from vector sequences.

Purpose of the Study:

  • To develop and evaluate novel, safer viral vectors for gene therapy.
  • To assess the efficacy and safety profile of new vectors in clinical trials for SCID-X1.

Main Methods:

  • Development of modified viral vectors with reduced oncogenic potential.
  • Preclinical safety studies of the new vectors.
  • Clinical trials using the new vectors in patients with SCID-X1.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.5K
CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
08:22

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

Published on: March 12, 2018

14.3K

Related Experiment Videos

Last Updated: Apr 25, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

7.6K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.5K
CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
08:22

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

Published on: March 12, 2018

14.3K

Main Results:

  • New vectors demonstrated improved safety in preclinical evaluations.
  • Early clinical trials in SCID-X1 patients showed evidence of therapeutic efficacy.
  • Preliminary integration analysis suggests a better safety profile compared to earlier vectors.

Conclusions:

  • The development of safer viral vectors is crucial for advancing gene therapy.
  • The new vectors show potential for effective and safer treatment of SCID-X1.
  • Ongoing research and analysis are vital to confirm long-term safety and efficacy.